Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Reich C"'
Autor:
Lloyd PC; US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: patricia.lloyd@fda.hhs.gov., Lufkin B; Acumen LLC, Burlingame, CA, USA., Moll K; IBM Consulting, Bethesda, MD, USA., Ogilvie RP; Optum Epidemiology, Boston, MA, USA., McMahill-Walraven CN; CVS Health, Blue Bell, PA, USA., Beachler DC; Carelon Research, Wilmington, DE, USA., Kelman JA; Centers for Medicare & Medicaid Services, Baltimore, MD, USA., Shi X; Acumen LLC, Burlingame, CA, USA., Hobbi S; IBM Consulting, Bethesda, MD, USA., Amend KL; Optum Epidemiology, Boston, MA, USA., Djibo DA; CVS Health, Blue Bell, PA, USA., Shangguan S; Acumen LLC, Burlingame, CA, USA., Shoaibi A; US Food and Drug Administration, Silver Spring, MD, USA., Sheng M; IBM Consulting, Bethesda, MD, USA., Secora A; IQVIA, Falls Church, VA, USA., Zhou CK; US Food and Drug Administration, Silver Spring, MD, USA., Kowarski L; IBM Consulting, Bethesda, MD, USA., Chillarige Y; Acumen LLC, Burlingame, CA, USA., Forshee RA; US Food and Drug Administration, Silver Spring, MD, USA., Anderson SA; US Food and Drug Administration, Silver Spring, MD, USA., Muthuri S; IBM Consulting, Bethesda, MD, USA., Seeger JD; Optum Epidemiology, Boston, MA, USA., Kline A; CVS Health, Blue Bell, PA, USA., Reich C; IQVIA, Falls Church, VA, USA., MaCurdy T; Acumen LLC, Burlingame, CA, USA; Department of Economics, Stanford University, Stanford, CA, USA., Wong HL; US Food and Drug Administration, Silver Spring, MD, USA.
Publikováno v:
Vaccine [Vaccine] 2024 Mar 19; Vol. 42 (8), pp. 2004-2010. Date of Electronic Publication: 2024 Feb 22.
Autor:
Moll K; IBM Consulting, Bethesda, MD, USA., Lufkin B; Acumen LLC, Burlingame, CA, USA., Fingar KR; IBM Consulting, Bethesda, MD, USA., Ke Zhou C; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Tworkoski E; Acumen LLC, Burlingame, CA, USA., Shi C; Acumen LLC, Burlingame, CA, USA., Hobbi S; IBM Consulting, Bethesda, MD, USA., Hu M; Acumen LLC, Burlingame, CA, USA., Sheng M; IBM Consulting, Bethesda, MD, USA., McCarty J; IBM Consulting, Bethesda, MD, USA., Shangguan S; Acumen LLC, Burlingame, CA, USA., Burrell T; IBM Consulting, Bethesda, MD, USA., Chillarige Y; Acumen LLC, Burlingame, CA, USA., Beers J; IBM Consulting, Bethesda, MD, USA., Saunders-Hastings P; Gevity Inc, an Accenture Company, Ottawa, Canada., Muthuri S; IBM Consulting, Bethesda, MD, USA., Edwards K; IBM Consulting, Bethesda, MD, USA., Black S; IBM Consulting, Bethesda, MD, USA., Kelman J; Centers for Medicare & Medicaid Services, Baltimore, MD, USA., Reich C; IQVIA, Falls Church, VA, USA., Amend KL; Optum Epidemiology, Boston, MA, USA., Djibo DA; Aetna, Blue Bell, PA, USA., Beachler D; HealthCore, Inc, Wilmington, DE, USA., Ogilvie RP; Optum Epidemiology, Boston, MA, USA., Secora A; IQVIA, Falls Church, VA, USA., McMahill-Walraven CN; Aetna, Blue Bell, PA, USA., Seeger JD; Optum Epidemiology, Boston, MA, USA., Lloyd P; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Thompson D; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Dimova R; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., MaCurdy T; Acumen LLC, Burlingame, CA, USA; Department of Economics, Stanford University, Stanford, CA, USA., Obidi J; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Anderson S; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Forshee R; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Wong HL; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA., Shoaibi A; U.S. Food and Drug Administration, Center for Biologics Evaluation and Research, Silver Spring, MD, USA. Electronic address: Azadeh.Shoaibi@fda.hhs.gov.
Publikováno v:
Vaccine [Vaccine] 2023 Jan 09; Vol. 41 (2), pp. 333-353. Date of Electronic Publication: 2022 Nov 08.
Autor:
Lloyd PC; US Food and Drug Administration, Silver Spring, MD, USA., Hu M; Acumen LLC, Burlingame, CA, USA., Wong HL; US Food and Drug Administration, Silver Spring, MD, USA., Shoaibi A; US Food and Drug Administration, Silver Spring, MD, USA., Ke Zhou C; US Food and Drug Administration, Silver Spring, MD, USA., Lo AC; Acumen LLC, Burlingame, CA, USA., Amend K; Optum Epidemiology, Boston, MA, USA., Beachler DC; HealthCore, Inc, Wilmington, DE, USA., McMahill-Walraven CN; CVS Health Clinical Trial Services, Blue Bell, PA , USA., Smith ER; Acumen LLC, Burlingame, CA, USA., Seeger J; Optum Epidemiology, Boston, MA, USA., Secora A; IQVIA, Falls Church, VA, USA., Audrey Djibo D; CVS Health Clinical Trial Services, Blue Bell, PA , USA., Obidi J; US Food and Drug Administration, Silver Spring, MD, USA., Feng Y; Acumen LLC, Burlingame, CA, USA., Song J; Optum Epidemiology, Boston, MA, USA., Reich C; IQVIA, Falls Church, VA, USA., Harris C; CVS Health Clinical Trial Services, Blue Bell, PA , USA., Akhtar S; Acumen LLC, Burlingame, CA, USA., Clifford R; Optum Epidemiology, Boston, MA, USA., Selvam N; IQVIA, Falls Church, VA, USA., Pigoga JL; CVS Health Clinical Trial Services, Blue Bell, PA , USA., Jiao Y; Acumen LLC, Burlingame, CA, USA., Chillarige Y; Acumen LLC, Burlingame, CA, USA., MaCurdy T; Acumen LLC, Burlingame, CA, USA., Forshee R; US Food and Drug Administration, Silver Spring, MD, USA., Anderson SA; US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: steven.anderson@fda.hhs.gov.
Publikováno v:
Vaccine [Vaccine] 2022 Oct 26; Vol. 40 (45), pp. 6481-6488. Date of Electronic Publication: 2022 Sep 27.